Evidence map›Paper›PMID 31872045›Full record

ArticleSmall methods2018

Near Infrared Boron Dipyrromethene Nanoparticles for Optotheranostics.

Ling Huang, Gang Han

Abstract read
In one paragraph

Article in Small methods, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Ling HuangDepartment of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, MA 01605, USA.
Gang HanDepartment of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, MA 01605, USA.

Funding

Wireless Optogenetics by relay nano-illuminatorsR01MH103133 · NIMH · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI HAN, GANG · 2013 to 2016
$1.3M
Optogenetic toolkit for remote control of voltage-gated calcium channelsR21GM126532 · NIGMS · TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR · PI HAN, GANG, ZHOU, YUBIN · 2018 to 2019
$443k
NIGMS NIH HHS R21 GM126532NIMH NIH HHS R01 MH103133
6 · The paper itself

Abstract

Boron dipyrromethene (BODIPY) is a class of important emerging fluorescent dyes. Due to their unique chemical and optical properties, near infrared (NIR)-emitting BODIPY dyes containing nanoparticles have recently been developed for a wide array of cutting-edge cancer optotheranostic applications. These nanoparticles not only have robust photostability and tunable photophysical properties, but they can also be flexibly tailored to a multitude of functional uses. Based on these outstanding characteristics, such nanoparticles have shown great promise in diagnosis as biological sensors, as well as in their utilization in advanced imaging and photomedicine for cancer treatment. In particular, here, this study first discusses their use as photoswitchable fluorescence probes toward in vitro single-molecule imaging. Second, this study takes a look at their opportunities for photoacoustic imaging utilization. Third, approaches are discussed to construct new NIR-absorbing BODIPY nanoparticles for photodynamic therapy (PDT). Fourth, this study delves into the new approach to use such nanoparticles as an emerging version of triplet-triplet annihilation upconversion (TTA-UC) and their biological uses, such as their photoactivation prodrug therapy (PAPT) for cancer. Finally, new biological sensors based on NIR BODIPY nanoparticles are introduced.

Indexed as

BODIPYcancernear infraredoptotheranostics

Identifiers

PMID31872045
PMCPMC6927252

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.